Other Income & Expense
Derivative Gain (Loss) Excluded from Effectiveness
CRH Derivative Gain (Loss) Excluded from Effectiveness decreased by 200.0% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 250.0%, from $2.00M to -$3.00M.
Analysis
StatementIncome Statement
SectionOther Income & Expense
First reportedQ2 2023
Last reportedQ1 2026Apr 30, 2026
Metric ID:
abbv_derivative_gain_loss_excluded_from_effectivenessHistorical Data
9 periods
| Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | -$1.00M | $2.00M | $2.00M | $2.00M | $3.00M | -$3.00M |
| QoQ Change | — | — | — | — | +300.0% | +0.0% | +0.0% | +50.0% | -200.0% |
| YoY Change | — | — | — | — | — | — | +300.0% | +50.0% | -250.0% |
Range-$3.00M – $3.00M
Avg YoY Growth+33.3%
Median YoY Growth+50.0%
Derivative Gain (Loss) Excluded from Effectiveness at Other Companies
Frequently Asked Questions
- What is CRH's derivative gain (loss) excluded from effectiveness?
- CRH (CRH) reported derivative gain (loss) excluded from effectiveness of -$3.00M in Q1 2026.
- How has CRH's derivative gain (loss) excluded from effectiveness changed year-over-year?
- CRH's derivative gain (loss) excluded from effectiveness decreased by 250.0% year-over-year, from $2.00M to -$3.00M.